SC Harvester Papers Database Interface

S1257 Smoking Increases the Risk for Cirrhosis and Esophageal Varices Among Patients With Non-Alcoholic Fatty Liver Disease

E. Krishtopaytis, Prabhat Kumar, A. Almomani, Somtochukwu Onwuzo, A. Boustany et al. In: The American Journal of Gastroenterology. 2022

Abstract: Eduard Krishtopaytis, MD1, Prabhat Kumar, MD1, Ashraf Almomani, MD1, Somtochukwu Onwuzo, MD1, Antoine Boustany, MD, MPH1, Dana Alshaikh, MD2, Almaza A. Albakri, MD3, Motasem Alkhayyat, MD1, Imad Asaad, MD4, Khaled Alsabbagh Alchirazi, MD5. Cleveland Clinic Foundation, Cleveland, OH; Mutah University, Amman, Al Karak, Jordan; Royal Jordanian Medical Services, Amman, Al Karak, Jordan; Cleveland Clin...

S443 Hypogonadism and Testosterone Replacement Therapy Are Associated with a Higher Risk of GERD in Males: A National Cohort Study

Y. Abu-Omar, R. Nanah, Khaled Alchirazi, Abdul Mohammed, M. Sanaka et al. In: The American Journal of Gastroenterology. 2022

Abstract: is the between has not been well literature.Precisely, the of on has been con literature. The aim of our study is to determine therisk of GERD and its complications among with hypogonadism and the risk of and its complications with those who with hypogonadism. We Cleveland, OH) includes on...

S1042 Comparison of Colectomy Rates in Biologic Naive Ulcerative Colitis Patients on Ustekinumab and Vedolizumab

Khaled Alchirazi, Ahmed Eltelbany, O. Hamid, E. Robalino Gonzaga, R. Garg et al. In: The American Journal of Gastroenterology. 2022

S964 Impact of Biologics Therapy on the Prevalence of Erectile Dysfunction Among Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Study

Khaled Alchirazi, O. Hamid, R. Nanah, Abdul Mohammed, M. Regueiro. In: The American Journal of Gastroenterology. 2022

Abstract: Introduction: Erectile dysfunction (ED) is a well-established comorbidity of In fl ammatory bowel disease (IBD). However, the connection between the two diseases remains unclear. Previous studies have suggested that chronic in fl ammation resulting in endothelial dysfunction maybe a contributing factor in the pathology of ED. Biologics have been shown to decrease in fl ammation among IBD patients. Th...

S973 Impact of Obesity on Outcomes of Patients With Inflammatory Bowel Disease: A National Inpatient Sample Analysis

Y. Abu-Omar, R. Nanah, Khaled Alchirazi, Joud Arnouk, George Khoudari et al. In: The American Journal of Gastroenterology. 2022

Abstract: of ustekinumab and vedolizumab on intestinal resection rates in bio-na¨ ı ve CD patients. Methods: A commercial database (Explorys Inc, Cleveland, OH) was utilized, which included electronic health record data from 26 major integrated US healthcare systems. We identi fi ed bio-na¨ ı ve CD patients. The primary outcome was to examine the association between anti-tumor necrosis factor (anti-TNF) medi...

S214 Clinicopathological Characteristics and Management of High-Grade Immune-Related Colitis

Khaled Alchirazi, A. Almomani, A. Boustany, Abel Joseph, Mohammed El-Dallal et al. In: The American Journal of Gastroenterology. 2022

Abstract: showed higher CMV abundance was associated with significantly decreased survival (p50.04) (Figure). When stratified by age, individuals aged$65 with higher CMV abundance had increased overall mortality risk (HR 1.21; p, 0.001) while no significant association was observed between CMV abundance and survival in those aged #55 (Table). Spearman correlation analysis showed intratumoral CMV signatures ...

S806 Impact of Biologics Therapy on the Prevalence of Pregnancy Complications Among Women With Inflammatory Bowel Disease: A Nationwide Population-Based Study

Khaled Alchirazi, O. Hamid, George Khoudari, M. Regueiro. In: The American Journal of Gastroenterology. 2022

S914 Impact of Anti-TNF on the Prevalence of Hepatobiliary and Pancreatic Disorders Associated With Inflammatory Bowel Disease: A Population-Based Study

O. Hamid, Khaled Alchirazi, Ahmed Eltelbany, R. Nanah, Abdul Mohammed et al. In: The American Journal of Gastroenterology. 2022

Abstract: in are of and about are an important aspect of their are to evaluate the and readability of online information related to contraception...

S3273 A Rare Case of Antiphospholipid Syndrome Presenting With Variceal Bleeding and Ascites Secondary to Portal Vein Thrombosis Without Liver Cirrhosis

Ahmed Eltelbany, R. Nanah, O. Hamid, S. Trakroo, Khaled Alchirazi et al. In: American Journal of Gastroenterology. 2022

S809 Impact of Biologics Therapy on the Prevalence of Parkinson’s Disease Among Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Study

Khaled Alchirazi, O. Hamid, Abdul Mohammed, M. Regueiro. In: The American Journal of Gastroenterology. 2022

Abstract: Introduction: In fl ammatory bowel disease(IBD) and Parkinson ’ s disease (PD) are chronic progressive disorders that mainlya ff ect di ff erent organs: the gut and brain,respectively. Increasing evidence supports reciprocalcommunication betweenthe enteric and thecentral nervous system in disease, termed the ’ gut-brainaxis ’ . Biologicshave been shownto decrease in fl ammation among IBD patients howe...

S1263 The Prevalence and Patient Characteristics of Hepatic Porphyria: A National Database Study

Khaled Alchirazi, T. Qapaja, Osama Abu-Shawer, S. Laique, Omar I. Massoud. In: The American Journal of Gastroenterology. 2022

Abstract: in fl ammatory cholestatic liver the bile duct. PBC is frequently associated with varying degrees of liver fi brosis measured by fi broscan. as in fl ammation, cytokine signaling, and abnormalinteractionamongst cholangiocytesand mesenchymalcells contributetothe development of fi brosis. Firstlinetreatment is ursodiol (UDCA) therapy. This study aims to elucidate the consequences of liver fi brosis on the...

S1338 The Prevalence of Protein-Calorie Malnutrition Among Patients With Alcoholic, Non-Alcoholic and Chronic Viral Cirrhosis in the United States: A Population-Based Study

Somtochukwu Onwuzo, A. Almomani, Prabhat Kumar, E. Krishtopaytis, Almaza A. Albakri et al. In: The American Journal of Gastroenterology. 2022

S1213 Predictors of Hepatotoxicity in Patients Receiving Immune Checkpoint Inhibitors: A Large Population-Based Study

Ahmed Eltelbany, Khaled Alchirazi, R. Nanah, Abdul Mohammed, Omar I. Massoud. In: The American Journal of Gastroenterology. 2022

S1252 Prevalence of Diagnosed Primary Biliary Cholangitis and Associated Conditions in the United States: Results From a National Electronic Patient Database

Khaled Alchirazi, Abdul Mohammed, Nour Azzouz, A. Almomani, S. Laique et al. In: The American Journal of Gastroenterology. 2022

Abstract: Introduction: Post-hospital discharge (PHD) clinics aim to prevent readmissions and cut healthcare costs. This is important in patients with liver disease who require close monitoring of labs, symptoms and complications. We anticipate that by mitigating hospital necessitating treatments, PHD appointments will reduce readmission rates. Methods: A retrospective chart review was performed of 258 pati...

S1177 Use of GLP1 Agonists or SGLT2 Inhibitors in Non-Alcoholic Steatohepatitis Patients With T2DM Is Associated With a Lower Risk of Cirrhosis: A Nationwide Population-Based Study

O. Hamid, Khaled Alchirazi, Abdul Mohammed, Omar I. Massoud. In: The American Journal of Gastroenterology. 2022

Abstract: Introduction: Non-alcoholicsteatohepatitis(NASH)isbecomingincreasinglyprevalentandaleadingcauseof cirrhosis.Unfortunately,besideslifestylechanges, therapeuticoptionsspeci fi callytargetingNASH are limited. Previous single center studies have suggested that glucagon-like peptide receptor (GLP1) agonists and sodium glucose co-transporter-2 (SGLT2)inhibitors may have a bene fi cial e ff ect. We sought t...